Antioxidant activity of synovial fluid, hyaluronic acid, and two subcomponents of hyaluronic acid. Synovial fluid scavenging effect is enhanced in rheumatoid arthritis patients. 1988

H Sato, and T Takahashi, and H Ide, and T Fukushima, and M Tabata, and F Sekine, and K Kobayashi, and M Negishi, and Y Niwa
First Department of Internal Medicine, School of Medicine, Showa University, Tokyo, Japan.

To test the scavenging of reactive oxygen species (ROS), we added synovial fluids from patients with rheumatoid arthritis (RA) and osteoarthritis, as well as hyaluronic acid (HA) and its 2 subcomponents, D-glucuronic acid and N-acetyl-D-glucosamine, to 2 ROS-generating systems, activated neutrophils and xanthine-xanthine oxidase. Synovial fluid from RA patients, HA, and D-glucuronic acid markedly decreased the O2-, H2O2, OH., and chemiluminescence measured in both systems. HA and synovial fluid, which are known to be susceptible to degradation by excessive ROS in RA patients, also seem to play an active role in protecting articular tissues from oxidative damage.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010003 Osteoarthritis A progressive, degenerative joint disease, the most common form of arthritis, especially in older persons. The disease is thought to result not from the aging process but from biochemical changes and biomechanical stresses affecting articular cartilage. In the foreign literature it is often called osteoarthrosis deformans. Arthritis, Degenerative,Osteoarthrosis,Osteoarthrosis Deformans,Arthroses,Arthrosis,Arthritides, Degenerative,Degenerative Arthritides,Degenerative Arthritis,Osteoarthritides,Osteoarthroses
D010100 Oxygen An element with atomic symbol O, atomic number 8, and atomic weight [15.99903; 15.99977]. It is the most abundant element on earth and essential for respiration. Dioxygen,Oxygen-16,Oxygen 16
D010101 Oxygen Consumption The rate at which oxygen is used by a tissue; microliters of oxygen STPD used per milligram of tissue per hour; the rate at which oxygen enters the blood from alveolar gas, equal in the steady state to the consumption of oxygen by tissue metabolism throughout the body. (Stedman, 25th ed, p346) Consumption, Oxygen,Consumptions, Oxygen,Oxygen Consumptions
D005260 Female Females
D005609 Free Radicals Highly reactive molecules with an unsatisfied electron valence pair. Free radicals are produced in both normal and pathological processes. Free radicals include reactive oxygen and nitrogen species (RONS). They are proven or suspected agents of tissue damage in a wide variety of circumstances including radiation, damage from environment chemicals, and aging. Natural and pharmacological prevention of free radical damage is being actively investigated. Free Radical
D005944 Glucosamine 2-Amino-2-Deoxyglucose,Dona,Dona S,Glucosamine Sulfate,Hespercorbin,Xicil,2 Amino 2 Deoxyglucose,Sulfate, Glucosamine
D005965 Glucuronates Derivatives of GLUCURONIC ACID. Included under this heading are a broad variety of acid forms, salts, esters, and amides that include the 6-carboxy glucose structure. Glucosiduronates,Glucuronic Acids,Acids, Glucuronic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

H Sato, and T Takahashi, and H Ide, and T Fukushima, and M Tabata, and F Sekine, and K Kobayashi, and M Negishi, and Y Niwa
December 1978, Experientia,
H Sato, and T Takahashi, and H Ide, and T Fukushima, and M Tabata, and F Sekine, and K Kobayashi, and M Negishi, and Y Niwa
January 1949, The Journal of clinical investigation,
H Sato, and T Takahashi, and H Ide, and T Fukushima, and M Tabata, and F Sekine, and K Kobayashi, and M Negishi, and Y Niwa
November 1962, Clinica chimica acta; international journal of clinical chemistry,
H Sato, and T Takahashi, and H Ide, and T Fukushima, and M Tabata, and F Sekine, and K Kobayashi, and M Negishi, and Y Niwa
November 1955, Clinical science,
H Sato, and T Takahashi, and H Ide, and T Fukushima, and M Tabata, and F Sekine, and K Kobayashi, and M Negishi, and Y Niwa
April 1964, Clinica chimica acta; international journal of clinical chemistry,
H Sato, and T Takahashi, and H Ide, and T Fukushima, and M Tabata, and F Sekine, and K Kobayashi, and M Negishi, and Y Niwa
January 1986, Vutreshni bolesti,
H Sato, and T Takahashi, and H Ide, and T Fukushima, and M Tabata, and F Sekine, and K Kobayashi, and M Negishi, and Y Niwa
January 1991, Clinical and experimental rheumatology,
H Sato, and T Takahashi, and H Ide, and T Fukushima, and M Tabata, and F Sekine, and K Kobayashi, and M Negishi, and Y Niwa
January 1968, Acta medica Polona,
H Sato, and T Takahashi, and H Ide, and T Fukushima, and M Tabata, and F Sekine, and K Kobayashi, and M Negishi, and Y Niwa
January 1983, Terapevticheskii arkhiv,
H Sato, and T Takahashi, and H Ide, and T Fukushima, and M Tabata, and F Sekine, and K Kobayashi, and M Negishi, and Y Niwa
June 1990, Clinical and experimental immunology,
Copied contents to your clipboard!